💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Immunomedics, Inc. (IMMU)
« Back to company indexIMMU Chatter Timeline
Stock Ticker for IMMU
Most Active Tweeters for IMMU
| User | Tweets |
|---|---|
| @biotechradar_eu | 3 |
| @GT20216 | 2 |
| @BurchetJohn | 1 |
| @redacre | 1 |
| @trademarktrader | 1 |
Recent Tweets for IMMU
 |
@GT20216 @BurchetJohn @lifeofhp Thanks! Somehow, I can’t find the ticker $IMMU ?? June 19th 2021, 12:06pm |
 |
@BurchetJohn @GT20216 @lifeofhp $immu https://t.co/giMRjXd4vN June 19th 2021, 12:06pm |
|
@GT20216 @BurchetJohn @lifeofhp May I ask why $IMMU? June 19th 2021, 11:06am |
 |
@Redeye_ Redeye regards the capital raise as an expected and logical step for Immunicum. Read our analyst's take: $IMMU https://t.co/xS3gepDFsr June 18th 2021, 8:06am |
 |
@biotechradar_eu Immunicum $IMMU Announces Results of Directed Share Issue https://t.co/ZK5iCyo56r June 17th 2021, 8:06pm |
|
@biotechradar_eu Immunicum $IMMU Announces its Intention to Carry Out a Directed Share Issue https://t.co/sRiipKivMl June 17th 2021, 3:06pm |
 |
@askwarrenbuffet $CLSK CEO To Be Featured On "CNNMoney" Segment Next Week Gaining Extensive Exposure https://t.co/Mv3xmUJu9A $IMMU… https://t.co/YWGXi9tsfn June 13th 2021, 4:06am |
 |
@trademarktrader TRODELVY is pending trademark approval; filing by IMMUNOMEDICS, INC. https://t.co/G1Us9tlhAC #TRODELVY $IMMU https://t.co/UTUnw7DAgO June 13th 2021, 2:06am |
 |
@redacre Biotech/HC New or revisited 52-Week Lows: $IMMU $VRTX June 11th 2021, 8:06pm |
|
@biotechradar_eu Immunicum $IMMU Presents Data on Clinical Program DCP-001 at the European Hematology Association (EHA) 2021 Virtual… https://t.co/hGKEE53yAM June 11th 2021, 7:06am |
 |
@stockassassin74 RT @haodongvli: $IOVA data getting stronger, adding, hope its another $IMMU June 7th 2021, 6:06pm |
 |
@haodongvli $IOVA data getting stronger, adding, hope its another $IMMU June 7th 2021, 1:06pm |
|
@askwarrenbuffet $HQGE CEO To Be Featured On "CNNMoney" Segment Next Week Gaining Extensive Exposure https://t.co/Mv3xmUJu9A $IMMU… https://t.co/hZOjO7BbZN June 4th 2021, 2:06am |
 |
@Kguy2N @AnthemTrading my fave downgrade ever. GS on $immu May 28th 2021, 5:05pm |
|
@askwarrenbuffet $NPHC CEO To Be Featured On "CNNMoney" Segment Next Week Gaining Extensive Exposure https://t.co/Mv3xmUJu9A $IMMU… https://t.co/IIvnEbzPkQ May 27th 2021, 3:05am |
 |
@bearcapital1 @MSS1992BIO No chance it’s gonna be Gileads biggest waste of money lol. Between $IMMU and $GLPG May 23rd 2021, 3:05pm |
 |
@biostockguru RT @outremer511: The board of $IOVA appears about as sentimental as the board of $IMMU was before they canned their penultimate CEO who cou… May 22nd 2021, 8:05pm |
 |
@Dreesenkl RT @outremer511: @IovanceBio See the thread above for how to solve your problems. Behzad turned $IMMU into a multi-billion dollar company.… May 22nd 2021, 8:05pm |
 |
@outremer511 @IovanceBio See the thread above for how to solve your problems. Behzad turned $IMMU into a multi-billion dollar co… https://t.co/DY9DrzQrAV May 22nd 2021, 8:05pm |
|
@outremer511 The board of $IOVA appears about as sentimental as the board of $IMMU was before they canned their penultimate CEO… https://t.co/caWJgD2y2n May 22nd 2021, 7:05pm |
 |
@YuZhu4 RT @haodongvli: $IOVA adding here, similar to $IMMU, QA QC validation issues, turn over of CEOs, end of the day, clinical data will rule. May 19th 2021, 5:05pm |
|
@haodongvli $IOVA adding here, similar to $IMMU, QA QC validation issues, turn over of CEOs, end of the day, clinical data will rule. May 19th 2021, 5:05pm |
 |
@Biohazard3737 Reminds me of $IMMU. Does Behzad have some spare time? $IOVA May 19th 2021, 4:05pm |
 |
@realmaciej RT @haodongvli: $IOVA reminds me of $IMMU: delay delay delay, SOP validation, SOP validation......, until a monster buyout! May 19th 2021, 1:05am |
|
@haodongvli $IOVA reminds me of $IMMU: delay delay delay, SOP validation, SOP validation......, until a monster buyout! May 18th 2021, 10:05pm |
 |
@The_Bullionaire $IMMU got bought out for $21 billion with no revenue and a 1 drug in phase 2 you clearly know nothing about biotech… https://t.co/K5yp65BfLV May 14th 2021, 4:05pm |
 |
@ConvictionCap_ @PaulKChoi impressive call on $IMMU last year, really nailed that one! $AMRN will make you look almost as clueless. Just a matter of time. May 12th 2021, 9:05pm |
|
@biotechradar_eu Immunicum $IMMU Announces Presentations at the European Hematology Association (EHA) 2021 Virtual Congress https://t.co/taReGdABg5 May 12th 2021, 2:05pm |
|
@askwarrenbuffet $TXHE CEO To Be Featured On "CNNMoney" Segment Next Week Gaining Extensive Exposure https://t.co/Mv3xmUJu9A $IMMU… https://t.co/lGrUuIEt3S May 11th 2021, 12:05am |
 |
@StkOptionCoach_ RT @StockTradersHQ: $IMMU now up over 100% since our original buy point of $3.20. See chart for buy points. http://t.co/TJFA3Ztfz4 May 8th 2021, 5:05am |
|
@StkOptionCoach_ RT @StockTradersHQ: From the chart section in last night's STHQ report $IMMU nice bounce off the LOD here. May 8th 2021, 5:05am |
|
@biotechradar_eu Immunicum $IMMU Interim Report January – March 2021 https://t.co/FRRafVSsEW May 4th 2021, 6:05am |
|
@biotechradar_eu Immunicum $IMMU Presents Preclinical Data for Ilixadencel and DCP-001 at the 18th Cancer Immunotherapy Annual Meeti… https://t.co/ZnKawn4VHK May 3rd 2021, 6:05am |
|
@YuZhu4 RT @Biohazard3737: To this day, people seem to struggle with terminal value in Biotech. It‘s what made $IMMU worth the price tag. If yo… April 29th 2021, 2:04pm |
 |
@PersimmonTI @buysidebio @Biohazard3737 $IMMU It’s a good point — $IMMU “hefty” acquisition price included the DCF potential of… https://t.co/9hxaafVbqU April 29th 2021, 11:04am |
|
@Biohazard3737 To this day, people seem to struggle with terminal value in Biotech. It‘s what made $IMMU worth the price tag.… https://t.co/s0wdKbP3eT April 29th 2021, 11:04am |
|
@askwarrenbuffet $AMC CEO To Be Featured On "CNNMoney" Segment Next Week Gaining Extensive Exposure https://t.co/Mv3xmUJu9A $IMMU… https://t.co/2M2uuT5ZlV April 27th 2021, 12:04am |
 |
@JanEhses RT @BertrandBio: Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer $GILD $IMMU #Troveldy https://t.co/0LOdB1RkKR April 22nd 2021, 4:04am |
 |
@mediasentiment $IMMU new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 558 April 20th 2021, 4:04pm |
 |
@Biotech2050 RT @StevenReznik: $TGTX in addition to my comment earlier about Goldman coverage today another to review they lowered $IMMU to sell 5 targe… April 20th 2021, 4:04pm |
 |
@StevenReznik $TGTX in addition to my comment earlier about Goldman coverage today another to review they lowered $IMMU to sell 5… https://t.co/5pXjGdOQdc April 20th 2021, 4:04pm |
|
@biotechradar_eu Immunicum $IMMU Announces Presentations at Upcoming Scientific Conferences in April and May https://t.co/yi6jPIWmFF April 19th 2021, 6:04am |
|
@askwarrenbuffet $MXSG CEO To Be Featured On "CNNMoney" Segment Next Week Gaining Extensive Exposure https://t.co/Mv3xmUJu9A $IMMU… https://t.co/BAJFHSXHnK April 17th 2021, 1:04am |
 |
@lblegend33 @redacre $immu? Didn’t that get BO while back? April 14th 2021, 8:04pm |
 |
@Franca_ole FDA grants accelerated approval to sacituzumab govitecan for advanced urothelial #cancer #Trodelvy $IMMU $GILD https://t.co/sf5MnkCPeP April 14th 2021, 9:04am |
|
@biotechradar_eu Immunicum $IMMU Initiates Research Collaboration with Icahn School of Medicine at Mount Sinai https://t.co/zvuXJGkhwA April 14th 2021, 8:04am |
 |
@jq1234t @bigpharmaguy Don’t think that’s the right comparison. $IMMU FDA AA approval great but bigger driver was huge succe… https://t.co/yxriRtxLp0 April 9th 2021, 4:04pm |
 |
@JosephRamelli RT @bigpharmaguy: Probably an unpopular take but $FGEN here gives me shades of $IMMU a year ago. Both had separate issues and were in revie… April 9th 2021, 2:04pm |
 |
@bigpharmaguy Probably an unpopular take but $FGEN here gives me shades of $IMMU a year ago. Both had separate issues and were in… https://t.co/5wFFhIZZSS April 9th 2021, 1:04pm |
|
@Franca_ole #FDA grants regular approval to #sacituzumab govitecan for triple-negative breast cancer https://t.co/OWnOVz2XdZ $IMMU $CYDY #TNBC April 7th 2021, 10:04pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.
DrugPatentWatch Video Training
Decision-making for generic drug entry and branded drug lifecycle management
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
This course answers the following questions to help you adapt:
- ✓ When will key drug patents expire?
- ✓ How can I find, evaluate, and plan for generic market entry opportunities?
- ✓ How can I find proprietary out-of-court settlements and deal terms?